✨ Free AI Report
Fractyl Health, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Fractyl Health, Inc.
Research Preview

Fractyl Health, Inc.: Business Overview, Financials & Competitive Analysis

Fractyl Health is a metabolic therapeutics company developing novel procedural and gene therapies for type 2 diabetes and obesity treatment. The company's lead program, Revita, is an outpatient procedural therapy usin...

Analyst-debate audio for Fractyl Health, Inc.

AskCyborg analysts argue the bull and bear cases for Fractyl Health, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Fractyl Health, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
5/ 10Mixed

Cyborg Score thesis

Clinical-stage metabolic therapy play with meaningful upside if Revita gains FDA approval and commercialization succeeds, but...

Read the full analyst-debate transcript →
Industry Metabolic Therapeutics / Obesity and Type 2 Diabetes Treatment
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest Fractyl Health, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Fractyl Health, Inc. Overview

Pro stress-test →

Fractyl Health is a metabolic therapeutics company developing novel procedural and gene therapies for type 2 diabetes and obesity treatment. The company's lead program, Revita, is an outpatient procedural therapy using duodenal mucosal resurfacing to address metabolic dysfunction caused by high-fat and high-sugar diets.

Strategic Profile

Pro stress-test →

Fractyl is positioned at the intersection of GLP-1 resistance and next-generation metabolic disease therapy. With pivotal trial data expected in H2 2026 and an FDA De Novo submission pathway, the company is advancing from clinical to commercial-stage operations while maintaining significant institutional backing and a cash runway into early 2027.

Competitive Landscape

Pro stress-test →

Fractyl competes in the expanding obesity/metabolic disease treatment space against procedural competitors (EndoBarrier, AspireAssist), pharmaceutical GLP-1 leaders (Novo Nordisk, Eli Lilly), and emerging metabolic therapy platforms. Revita's unique duodenal resurfacing approach targets GLP-1 resistance/maintenance, positioning it as complementary to rather than directly competing with GLP-1 agonists.

Industry Context

Fractyl Health, Inc. operates in Metabolic Therapeutics / Obesity and Type 2 Diabetes Treatment.

Key facts

Founded: 2010 · Headquarters: Burlington, Massachusetts · Market cap: $72M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Fractyl Health, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Fractyl Health, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Duodenal mucosal resurfacing devicesCompeting duodenal intervention approaches→GLP-1 agonists and analogsDominant pharmacological obesity treatment→Metabolic gene therapiesEmerging gene therapy platforms for metabolic disease→

Compare Fractyl Health, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Fractyl Health, Inc. operates in Metabolic Therapeutics / Obesity and Type 2 Diabetes Treatment. See how the rest of the sector scores on the Cyborg framework.

Browse Metabolic Therapeutics / Obesity and Type 2 Diabetes Treatment research →
NEW · MCP server

Ask your AI assistant about Fractyl Health, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Fractyl Health, Inc. and its top competitor on Cyborg Score”
“What did Fractyl Health, Inc. do this quarter?”
“Is Fractyl Health, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Fractyl Health, Inc. do?+
Fractyl Health is a metabolic therapeutics company developing novel procedural and gene therapies for type 2 diabetes and obesity treatment. The company's lead program, Revita, is an outpatient procedural therapy usin...
What is Fractyl Health, Inc.'s Cyborg Score?+
Fractyl Health, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Fractyl Health, Inc.'s main competitors?+
Named competitors include Duodenal mucosal resurfacing devices, GLP-1 agonists and analogs, Metabolic gene therapies. The full competitive landscape is in the AskCyborg report.
How can I get the full Fractyl Health, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Fractyl Health, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Fractyl Health, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.